Sign inJoin waitlistJoin the waitlist

MO

Mohammad Omaira

Clinical Assistant Professor, Department of Medical Education · Western Michigan University Homer Stryker MD School of Medicine

Credentials: · · · ·

History

Western Michigan University Homer Stryker MD School of Medicine
Present

Hematology and Medical Oncology
Michigan State University
2011–2014
Internal Medicine-Pediatrics
Hurley Medical Center
2007–2011
Damascus University
2005–2006
DAMASCUS UNIV, DAMASCUS
2001–2005

Research

Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial
The Lancet Haematology · 2019 · 67 citations
Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL
Blood Advances · 2024 · 12 citations
Richter transformation to classical Hodgkin lymphoma following recurrent disseminated histoplasmosis in chronic lymphocytic leukemia: a Case Report
Case report · Frontiers in Oncology · 2026 · Last of 5 authors

Talal Al-Assil
4 papers · 2 as a resident
Alvaro Alencar
2 papers
Ann LaCasce
2 papers
Caron Jacobsen
2 papers
Danielle Brander
2 papers
David Fisher
2 papers
EH
Ephraim Hochberg
2 papers
Faisal Ansari
2 papers · 2 as a resident
Jennifer Brown
2 papers
Jennifer Crombie
2 papers · 1 as a fellow
JA
Jeremy Abramson
2 papers
Jon Arnason
2 papers

Clinical trials

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Site PI · Recruiting
Dana-Farber Cancer Institute
2014–2030